THC

InvestmentPitch Media Video Discusses StickIt Technologies and its Portfolio of Products Bringing New Enhanced Experiences to Consumers Smoking or Drinking Various Products

Retrieved on: 
Tuesday, March 12, 2024
Smoking, News, Cannabinoid, Terpene, Drinking, CBG, THC, Cannabis, Research, Drug

Vancouver, British Columbia--(Newsfile Corp. - March 12, 2024) - InvestmentPitch Media video features StickIt Technologies (CSE: STKT), a company at the forefront of the global cannabis industry with a portfolio of revolutionary products that bring new enhanced experiences to consumers smoking or drinking various products.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - March 12, 2024) - InvestmentPitch Media video features StickIt Technologies (CSE: STKT), a company at the forefront of the global cannabis industry with a portfolio of revolutionary products that bring new enhanced experiences to consumers smoking or drinking various products.
  • For more information, please view the InvestmentPitch Media video which provides additional information about this news and the company.
  • SipIt, another new product, is a special straw containing a hidden cartridge containing cannabinoids such as THC and CBD.
  • For more information, please visit the company's website www.stickit-labs.com , contact Eli Ben-Haroosh, CEO, by email at [email protected] .

RETRANSMISSION: Akanda Corp. Signs Share Purchase and Escrow Agreements for the Sale of Portuguese Assets to Somai Pharmaceuticals

Retrieved on: 
Friday, March 1, 2024
CBPM, USD, Amend, Sale, RPK, Medicine, LDA, Patient, CBD, THC, Akanda, Schedule 2, Resolution

This strategic move underscores both companies' commitment to advancing the medical cannabis industry and enhancing patient access to high-quality cannabis treatments.

Key Points: 
  • This strategic move underscores both companies' commitment to advancing the medical cannabis industry and enhancing patient access to high-quality cannabis treatments.
  • Under the terms of the Share Purchase Agreement, Somai will acquire RPK, Akanda's indirect Portuguese subsidiary, for a total consideration of Two Million United States Dollars (USD $2,000,000).
  • The execution of the Share Purchase Agreement and Escrow Agreement follows the Amended Non-Binding Letter of Intent ("LOI") announced on February 1, 2024, and represents a crucial step towards the transaction's completion.
  • The closing of the proposed sale is subject to customary due diligence, representations, warranties, covenants, indemnities, and other closing conditions.

Can B Corp. Secures Ownership and Control of Two Cannabis Patents Valued at $122 Million and Potentially in Excess of $750 Million

Retrieved on: 
Monday, March 11, 2024
OTCQB, Cancer, Anxiety, THCA, Shikimate pathway, Growth, CBN, Cannabinoid, European, Health, Ground substance, Chronic pain, Patent, Federal court, THC, PTSD, Cannabis, Sleep, IBS, Controlled Substances Act, Pharmaceutical industry

HICKSVILLE, NY, March 11, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Can B Corp., a Florida corporation (OTCQB: CANB) (“Can B”), a health and wellness company specializing in developing, producing and selling hemp-derived cannabinoid products, is pleased to announce that it has secured ownership and control of two cannabis patents that were valued at $122 million, applying a 90% discount and assuming a revenue stream through August 2034, and further based on only CBD claims and only in the U.S. It is believed that if the global THC and CBD markets were added to the valuation, then the value of the patents is potentially up to $750 million.

Key Points: 
  • It is believed that if the global THC and CBD markets were added to the valuation, then the value of the patents is potentially up to $750 million.
  • These patents were previously awarded to United Cannabis Corporation and recently assigned to Can B by a court procedure.
  • The patents were valued at $122 million in December 2020 by an independent third-party valuation team, which used a 90% discount rate due to the emerging nature of the industry.
  • We believe there is a strong opportunity to monetize these patents as they represent important innovations in this industry.

Evn Introduces a Game-Changer in Cannabis Edibles with New Hemp-Derived Live Resin Gummies

Retrieved on: 
Friday, March 8, 2024
Health, Hemp, Cannabis, CBD, THC, Drug

Live resin , the star ingredient in Evn's new product, is renowned for its superior quality and purity.

Key Points: 
  • Live resin , the star ingredient in Evn's new product, is renowned for its superior quality and purity.
  • Unlike traditional extracts, live resin captures a fuller profile of the cannabis plant's compounds, including its all of its flavors and aromas.
  • "We are incredibly proud to introduce our Live Resin Gummies to the market," stated CEO Josh Krumholz.
  • Evn's Hemp-derived Live Resin Gummies distinguish themselves from competitors through several unique selling points:
    The use of live resin, which provides a fresher and richer cannabis experience.

Brains Bioceutical Corp, the Global Leader in Natural Cannabinoid APIs, Introduces Revolutionary Solid THC, Ushering in a New Era of Clinical Research

Retrieved on: 
Tuesday, March 5, 2024
Mental health, Active ingredient, USD, API, Quality of life, Drug development, Hope, Pharmacy, Safety, Pain management, JCAC, D9, Health, Patient, THC, Medicine, Veteran, DSM-IV codes, Cannabis, Face

This milestone reflects the company's commitment to innovation and its position at the forefront of the cannabinoid pharmaceutical industry.

Key Points: 
  • This milestone reflects the company's commitment to innovation and its position at the forefront of the cannabinoid pharmaceutical industry.
  • This breakthrough not only signifies a significant advancement in cannabinoid research but also underscores our commitment to driving innovation in pharmaceuticals.” Ricky Brar CEO & Chairman of Brains Bio.
  • "As a scientist deeply involved in cannabinoid research, I am thrilled by Brains Bio announcement of the solid D9 THC API.
  • The solid D9 THC is not just a product; it’s a symbol of Brains Bio commitment to pioneering the future of healthcare and pharmaceuticals.

HYTN Clears PIC/S GMP Audit, Primed for Global Expansion

Retrieved on: 
Monday, March 4, 2024
TGA, Growth, PIC/S, GMP, Psilocybin, Therapeutic Goods Administration, Certification, THC, Cannabis, Drink, Partnership

The positive outcome of the audit has set the stage for the subsequent issuance of formal GMP certification allowing the company to access international medical markets.

Key Points: 
  • The positive outcome of the audit has set the stage for the subsequent issuance of formal GMP certification allowing the company to access international medical markets.
  • The GMP audit conducted by the TGA was performed in accordance with the standards of the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme ("PIC/S").
  • Once issued, GMP certification under the PIC/S framework allows HYTN to engage with international medical markets that recognize the PIC/S standard, through established reciprocal agreements.
  • This step also allows us to elevate our existing systems, bringing our current and future product offerings into compliance with GMP standards.”

Rubicon Organics Brings 1964 Supply Co. Cannabis-Infused Poutine Sauce to Quebec

Retrieved on: 
Thursday, February 29, 2024
Friends, CCO, Haute cuisine, Cannabis, THC, Drug

VANCOUVER, British Columbia, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics”, “Rubicon”, or the “Company”), a licensed producer focused on cultivating and selling organic certified, premium cannabis, today announces the launch of 1964 Supply Co.™ brand Cannabis-Infused Poutine Sauce crafted with hash rosin.

Key Points: 
  • VANCOUVER, British Columbia, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics”, “Rubicon”, or the “Company”), a licensed producer focused on cultivating and selling organic certified, premium cannabis, today announces the launch of 1964 Supply Co.™ brand Cannabis-Infused Poutine Sauce crafted with hash rosin.
  • “High Cuisine” is the new Haute Cuisine: 1964 Supply Co.™ Cannabis-Infused Poutine Sauce is now hitting the Quebec Market.
  • 1964 Supply Co.™ is thrilled to announce the launch of a fun and innovative cannabis product that will revolutionize your culinary experience: Cannabis-Infused Poutine Sauce!
  • But that's not all - following the Quebec launch, 1964 Supply Co.™ plans to expand its distribution of the infused poutine sauce to other provinces in the coming weeks, bringing the joy of Cannabis-Infused Poutine Sauce to even more consumers across the country.

Green Thumb Expands Florida Retail Footprint with New RISE Dispensary in Dunnellon, its 15th Location in the Sunshine State

Retrieved on: 
Thursday, February 29, 2024
City, Glaze, Commerce, Food, Thumb, Dispensary, Patient, CBD, THC, Golden Joystick Awards, Veteran, Music, Cannabis, Shine, Hospital

CHICAGO and VANCOUVER, British Columbia, Feb. 29, 2024 (GLOBE NEWSWIRE) -- RISE Dispensaries , a rapidly growing cannabis retail chain owned by Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), today announced the opening of its 15th retail location in Florida and 92nd nationwide, RISE Dispensary Dunnellon.

Key Points: 
  • CHICAGO and VANCOUVER, British Columbia, Feb. 29, 2024 (GLOBE NEWSWIRE) -- RISE Dispensaries , a rapidly growing cannabis retail chain owned by Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), today announced the opening of its 15th retail location in Florida and 92nd nationwide, RISE Dispensary Dunnellon.
  • Located at 11192 N. Williams St., RISE Dispensary Dunnellon will open on Friday, March 1, with special discounts and complimentary merchandise for the store’s first customers.
  • “We are thrilled to be the first dispensary to open in the City of Dunnellon, marking our second RISE location in Marion County,” said Green Thumb President Anthony Georgiadis.
  • “Located just west of our state-of-the-art cultivation facility in Ocala, RISE Dunnellon shall offer a highly curated product selection and best-in-class service.

Skye Bioscience Completes Enrollment of Phase 2a Clinical Trial of SBI-100 Ophthalmic Emulsion in Glaucoma and Ocular Hypertension

Retrieved on: 
Monday, February 26, 2024
OTCQB, SAN, IOP, Glaucoma, OE, Blood, Obesity, OHT, Eye, Database, Safety, Biomarker, CB1, Ocular hypertension, Patient, THC, Hyperaemia, Trial of the century, Isle of Skye, Pharmaceutical industry

All treated patients completed the study, with no early discontinuations due to adverse events.

Key Points: 
  • All treated patients completed the study, with no early discontinuations due to adverse events.
  • “Because this trial completed enrollment ahead of schedule, our initially intended interim data report based on partial enrollment is unnecessary.
  • Skye is evaluating SBI-100 OE’s ability to lower IOP, safety and relevant biomarkers in patients with POAG or OHT.
  • Low rate of hyperaemia (red eyes) of 8.4% compared to higher rates in other leading classes of glaucoma drugs.

Solei Brand Launches New Cannabis Infused Cold Brew Teas

Retrieved on: 
Thursday, February 22, 2024
Hibiscus, TSX, CBN, Tea, CBG, Drink, Chamomile, CBD, THC, TLRY, Tilray, Lavandula

TORONTO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer packaged goods company, today debuts two new ready-to-drink cold brew tea beverages by its premium cannabis wellness brand, Solei .

Key Points: 
  • TORONTO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer packaged goods company, today debuts two new ready-to-drink cold brew tea beverages by its premium cannabis wellness brand, Solei .
  • Introducing Peach Cranberry and Wildberry Hibiscus, Solei’s new cold brew tea offerings are non-carbonated and embrace a moderate elevation that’s mildly sweet and comes in 355ml per can.
  • Solei’s newly launched cold brew teas are produced with a black tea base and blended with real fruit juice to create a refreshing fizz-free experience.
  • Find out more about Solei’s Cold Brew Teas by visiting www.solei.ca and following our journey @soleicanada across socials.